Combined epineurial therapy with neutralizing antibodies to tumor necrosis factor-alpha and interleukin-1 receptor has an additive effect in reducing neuropathic pain in mice
Section snippets
Acknowledgements
We would like to thank B. Dekant and L. Biko for expert technical assistance. Supported by Volkswagenstiftung.
References (18)
- et al.
Synergy between tumor necrosis factor alpha and interleukin-1 in the induction of sickness behavior in mice
Psychoneuroendocrinology
(1994) - et al.
A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia
Pain
(1988) - et al.
Effects of neutralizing antibodies to TNF-alpha on pain-related behavior and nerve regeneration in mice with chronic constriction injury
Brain Res.
(2000) - et al.
Interleukin-1 beta induced-desArg9bradykinin-mediated thermal hyperalgesia in the rat
Neuropharmacology
(1994) - et al.
Intrathecally administered endotoxin or cytokines produce allodynia, hyperalgesia and changes in spinal cord neuronal responses to nociceptive stimuli in the rat
Eur. J. Pain
(2000) - et al.
Neutralizing antibodies to interleukin 1-receptor reduce pain associated behavior in mice with experimental neuropathy
Neurosci. Lett.
(1999) - et al.
Painful mononeuropathy in C57BL/Wld mice with delayed wallerian degeneration: differential effects of cytokine production and nerve regeneration on thermal and mechanical hypersensitivity
Brain Res
(1998) - et al.
Intrathecal interleukin-1 receptor antagonist in combination with soluble tumor necrosis factor receptor exhibits an anti-allodynic action in a rat model of neuropathic pain
Neuroscience
(2001) - et al.
Mechanisms of tumor necrosis factor-alpha (TNF-alpha) hyperalgesia
Brain Res.
(1995)
There are more references available in the full text version of this article.
Cited by (100)
A randomized, placebo-controlled, double-blinded mechanistic clinical trial using endotoxin to evaluate the relationship between insomnia, inflammation, and affective disturbance on pain in older adults: A protocol for the sleep and Healthy Aging Research for pain (SHARE-P) study
2023, Brain, Behavior, and Immunity - HealthTargeting cytokines for treatment of neuropathic pain
2017, Scandinavian Journal of PainIL-1 receptor antagonist improves morphine and buprenorphine efficacy in a rat neuropathic pain model
2015, European Journal of PharmacologyUrinary trypsin inhibitor attenuates the development of neuropathic pain following spinal nerve ligation
2015, Neuroscience Letters
Copyright © 2001 Elsevier Science Ireland Ltd. All rights reserved.